H

HLS

HLS Therapeutics

4.200

-0.050-1.18%

Closed15:50 07/03 EDT

1D

5D

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.170/4.250

TODAY RANGE4.170-4.220

VOL1.90K

MARKET CAP131.35M

52 WEEK RANGE4.000-5.77

AVG VOL (3M)34.08K

% TURNOVER0.01%

TURNOVER7.99K

P/E (TTM)-9.1623

% RANGE1.18%

EPS(TTM)-0.4584

P/E(FORWARD)-14.7887

P/B1.609

BVPS2.610

DIVIDEND--

P/S1.725

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP130.64M

SHARES OUTSTANDING31.27M

NEXT EARNINGS08/12-08/17

FREE FLOAT31.11M

LOT SIZE100

EX-DATE04/27/2023

News

Press Releases

Financial Reports

Profile

Dow Jones·06/26 21:00
Press Release: HLS Therapeutics Reports Annual Meeting Results
Dow Jones·06/23 11:14
HLS Therapeutics Gets TSX Green Light to Buy Back up to 8% of Public Float
Dow Jones·06/23 11:04
*HLS Therapeutics May Buy Back Up to 1.5M Shrs Under Program
Dow Jones·06/23 11:00
Press Release: HLS Therapeutics Announces Normal Course Issuer Bid
Dow Jones·05/15 11:03
*HLS Therapeutics Still Sees 2026 Adjusted Ebitda $18.5M-$21M >HLS.T
Dow Jones·05/15 11:02
*HLS Therapeutics Backs 2026 View of Rev $56M-$60M >HLS.T
Dow Jones·05/15 11:00
*HLS Therapeutics 1Q Rev $12.9M >HLS.T
Dow Jones·05/15 11:00
Press Release: HLS Therapeutics Announces Q1 2026 -2-
Dow Jones·05/15 11:00
Press Release: HLS Therapeutics Announces Q1 2026 Financial Results
Dow Jones·03/12 10:36
*HLS Therapeutics 4Q Loss/Shr 4c >HLS.T
Dow Jones·03/12 10:30
Press Release: HLS Therapeutics Announces Fiscal 2025 Financial Results
Dow Jones·03/12 10:30
Press Release: HLS Therapeutics Announces Fiscal -2-
Dow Jones·11/13/2025 11:32
*HLS Therapeutics Sees FY25 Rev $55M-$56M >HLS.T
Dow Jones·11/13/2025 11:31
*HLS Therapeutics 3Q Loss $3.92M >HLS.T
Dow Jones·11/13/2025 11:31
*HLS Therapeutics 3Q Rev $13.5M >HLS.T

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others